Akebia Therapeutics, Inc.
AKBA NASDAQ







Weekly Report
Akebia Therapeutics, Inc. closed at 2.8200 (-4.73% WoW) . Data window ends Fri, 19 Sep 2025.
How to read this โ Price slope is downward, indicating persistent supply pressure. Elevated weekly volatility increases whipsaw risk. Volume trend diverges from price โ watch for fatigue or rotation. Distance to baseline is narrowing โ reverting closer to its fair-value track. Price sits below key averages, keeping pressure on the tape.
Down-slope argues for patience; rallies can fade sooner unless participation improves. Because liquidity isnโt confirming, prefer evidence of fresh demand before chasing moves.
Gauge maps the trend signal to a 0โ100 scale.
How to read this โ Gauge is elevated but momentum is rolling over; topping risk is rising. Notable breakdown from โฅ0.80 weakens trend quality.
Stay alert: protect gains or seek confirmation before adding risk.
Conclusion
Negative setup. โ โโโโ confidence. Price window: -24. Trend: Uptrend at Risk; gauge 75. In combination, liquidity diverges from price.
- High-level but rolling over (topping risk)
- Momentum is weak/falling
- Price is not above key averages
- Liquidity diverges from price
Why: Price window -24.19% over 8w. Close is -24.19% below the prior-window high. Return volatility 4.69%. Volume trend rising. Liquidity divergence with price. Trend state uptrend at risk. High-regime (0.80โ1.00) downticks 5/5 (100.0%) โข Distributing. Momentum neutral and falling.
Tip: Most metrics include a hover tooltip where they appear in the report.